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Background
Parvoviridae are part of air-, parenteral- and perinatal-
transmitted ubiquitous viruses, whose associated signs
and symptoms strongly depend on patient’sa g ea n d
immune defence.
Methods
All cases of symptomatic Parvovirus B19 infection in
otherwise healthy adults which came to our attention
since spring 2006 were prospectively investigated and
followed-up.
Results
In a 21-month period, 11 patients (7 females and
4 males), with a mean age of 36.9 (range 27-46) years
with a symptomatic Parvovirus B19 infection were
recorded and followed-up. Intrafamiliar exposure and
occupational (health care) exposure were identified in
two cases each. Clinical signs and symptoms included
fever (100% of cases), polyarthralgia (90%), followed by
headache (80%), anemia (70%), and rash. A mild-to-
moderate myelosuppression of all hematological lines
characterized 8 cases of 11 (72.7%), while increased
serum transaminases were associated in 63.6% of
patients. Three patients of ours deserved hospitalization
(mean 10.8 days of admission), and five more cases were
followed on Day-Hospital basis (for a median 75-day
period); in four patients a treatment with i.v. high-
dosage human immunoglobulins was performed. Ele-
vated levels of specific serum anti-Parvovirus B19 IgM
antibodies were detected in all cases. In a 33-year-old
female a severe anemia and a persisting headache,
vomiting, and neck stiffness, led to RBC transfusion and
a diagnosis of meningoencephalitis, with positive search
of IgM antibodies and Parvovirus B19 viremia (detected
by RT-PCR) in the cerebrospional fluid which lasted up
to three months, despite treatment with i.v. serum
immunoglobulins.
Discussion
Parvovirus B19 infection may play a significant role also
in adult, immunocompetent subjects, and the disease
sometimes is not mild and self-limiting, requiring
admission and/or frequent outpatient interventions in a
significant number of cases. The causes supporting a
persistant infection in immunocompetent subjects have
not been investigated to date, as well as the pathogen-
esis of myelosuppression and severe polyartrhalgia.
Symptomatic Parvovirus B19 infection is still an under-
estimated clinical condition, and therapeutic perspec-
tives are extremely limited until now.
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